Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003739 | Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy | completed | Phase 3 | 67 | Children's Oncology GroupNETWORK | 7 | Feb 14, 2014 | clinicaltrials |
| NCT01428141 | A Phase I Study of E7050 in Subjects With Solid Tumors | completed | Phase 1 | 18 | Eisai Co., Ltd.INDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer |
| completed |
| Phase 1 |
| 47 |
| Georgetown UniversityOTHER |
| 1 |
| Feb 13, 2014 |
| clinicaltrials |
| NCT00276627 | Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer | completed | N/A | 800 | Duke UniversityOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00125840 | Clofarabine in Adult Patients With Advanced Solid Tumors | completed | Phase 1 | — | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00066248 | Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment | completed | Phase 2 | 70 | University of South FloridaOTHER | 3 | Feb 3, 2014 | clinicaltrials |
| NCT01168752 | Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma | completed | Phase 1 | 81 | Debiopharm International SAINDUSTRY | 1 | Feb 3, 2014 | clinicaltrials |
| NCT00377130 | Stress Management Therapy in Patients Receiving Chemotherapy for Cancer | completed | N/A | 442 | University of South FloridaOTHER | 2 | Jan 31, 2014 | clinicaltrials |
| NCT00400699 | Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer | completed | N/A | 3,150 | University of PittsburghOTHER | 1 | Jan 31, 2014 | clinicaltrials |
| NCT01612598 | Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials | completed | N/A | 16 | City of Hope Medical CenterOTHER | 1 | Jan 31, 2014 | clinicaltrials |
| NCT00391521 | AS703569 Phase I in Patients With Solid Tumours | completed | Phase 1 | 104 | EMD SeronoINDUSTRY | 1 | Jan 30, 2014 | clinicaltrials |
| NCT01273090 | Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma | completed | Phase 1 | 34 | Children's Oncology GroupNETWORK | 2 | Jan 30, 2014 | clinicaltrials |
| NCT00978523 | Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma | completed | Phase 1 | 35 | Arno TherapeuticsINDUSTRY | 2 | Jan 29, 2014 | clinicaltrials |
| NCT01170897 | Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | Halozyme TherapeuticsINDUSTRY | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00387920 | Sunitinib in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 2 | Jan 28, 2014 | clinicaltrials |
| NCT00725634 | A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma(P05538) | completed | Phase 1 | 41 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 27, 2014 | clinicaltrials |
| NCT01306630 | A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 24 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00827177 | Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors | completed | Phase 1 | 87 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 2 | Jan 24, 2014 | clinicaltrials |
| NCT00054288 | Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00084708 | Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 53 | Roswell Park Cancer InstituteOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00112892 | Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | Roswell Park Cancer InstituteOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00003768 | Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00769288 | FAU in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00004979 | Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors | completed | Phase 1 / Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Jan 6, 2014 | clinicaltrials |
| NCT00894049 | A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation(ITAC02-01) | completed | Phase 2 | 148 | Institut Paoli-CalmettesOTHER | 1 | Jan 1, 2014 | clinicaltrials |
| NCT00551096 | Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors | completed | Phase 1 | 23 | University of Colorado, DenverOTHER | 1 | Dec 25, 2013 | clinicaltrials |
| NCT00003697 | Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors | completed | Phase 1 | 3 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003698 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 | 35 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004051 | Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005791 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00008073 | Octreotide and Doxorubicin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00008086 | Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00009802 | Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 45 | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00072332 | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00301145 | Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking | completed | N/A | 1,200 | SRI InternationalINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00017524 | AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors | completed | Phase 1 | 22 | University of Alabama at BirminghamOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00080990 | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00243100 | Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00390052 | 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00007878 | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00021073 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 90 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00043121 | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00103220 | SJG-136 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00697437 | Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel | completed | Phase 2 | 10 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00927966 | RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms | completed | Phase 1 | 21 | Suzanne George, MDOTHER | 1 | Nov 14, 2013 | clinicaltrials |
| NCT00708006 | A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 66 | Human Genome Sciences Inc.INDUSTRY | 1 | Nov 7, 2013 | clinicaltrials |
| NCT01110486 | ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors | completed | Phase 1 | 102 | AbbVie (prior sponsor, Abbott)INDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00413283 | Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 63 | AmgenINDUSTRY | 8 | Oct 24, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00075634 | Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Feb 14, 2014source: clinicaltrials